Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 13.81 | 10.53 |
PEG Ratio (TTM) | -0.30 | -0.42 |
P/S Ratio (TTM) | 0.78 | 2.05 |
P/B Ratio (TTM) | 4.49 | 2.76 |
P/FCF Ratio (TTM) | 42.18 | 13.53 |
Price to 5YR AVG Earnings Ratio | N/A | 9.64 |
Price to 5YR AVG FCF Ratio | N/A | 9.10 |
Profitability (55%) |
Company | Industry |
---|---|---|
ROA (TTM) | 12.85% | 1.82% |
ROE (TTM) | 36.16% | 11.73% |
Net Profit Margin (TTM) | 5.61% | -78.60% |
ROIC 5YR AVG | N/A | 21.88% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -54.62% | N/A | N/A |
Revenue | -0.45% | N/A | N/A |
Net Income | -54.69% | N/A | N/A |
Cash Flow | -158.94% | N/A | N/A |
Health (58%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.72 | 1.82 |
Quick Ratio (TTM) | 0.54 | 0.88 |
D/E Ratio (TTM) | 0.28 | 1.57 |
Interest Coverage (TTM) | 42.81 | 18.48 |
Piotroski F-Score | 8 | 7 |
Altman Z-Score | 5.42 | 2.78 |
LTL to 5YR AVG FCF | N/A | 5.01 |
Shares Outstanding Growth 5YR AVG | N/A | -1.80% |